0001209191-21-012100.txt : 20210218 0001209191-21-012100.hdr.sgml : 20210218 20210218184641 ACCESSION NUMBER: 0001209191-21-012100 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210216 FILED AS OF DATE: 20210218 DATE AS OF CHANGE: 20210218 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Swisher Daniel N JR CENTRAL INDEX KEY: 0001323113 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-21937 FILM NUMBER: 21651216 MAIL ADDRESS: STREET 1: C/O SUNESIS PHARMACEUTICALS, INC. STREET 2: 395 OYSTER POINT BLVD., SUITE 400 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: CERUS CORP CENTRAL INDEX KEY: 0001020214 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] IRS NUMBER: 680262011 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 1220 CONCORD AVENUE STREET 2: SUITE 600 CITY: CONCORD STATE: CA ZIP: 94520 BUSINESS PHONE: 9252886000 MAIL ADDRESS: STREET 1: 1220 CONCORD AVENUE STREET 2: SUITE 600 CITY: CONCORD STATE: CA ZIP: 94520 FORMER COMPANY: FORMER CONFORMED NAME: CERUS TECHNOLOGIES INC DATE OF NAME CHANGE: 19960731 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2021-02-16 0 0001020214 CERUS CORP CERS 0001323113 Swisher Daniel N JR C/O CERUS CORPORATION 1220 CONCORD AVE CONCORD CA 94520 1 0 0 0 Common Stock 2021-02-16 4 M 0 10000 2.90 A 69868 D Common Stock 2021-02-16 4 S 0 10000 7.7797 D 59868 D Option (Right to Buy) 2.90 2021-02-16 4 M 0 10000 D 2021-06-26 Common Stock 10000 5000 D This transaction was executed pursuant to a 10b5-1 plan. The reported price in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.68 to $7.941 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the aforementioned range set forth. The option became exercisable in 12 equal monthly installments after the grant date. Not applicable. Daniel N. Swisher Jr. by Chrystal Menard, attorney-in-fact 2021-02-18